Assam: Banned Tablets, Cough Syrup Seized In Nagaon, 2 Arrested

Nagaon : Police apprehended two persons and recovered a large quantity of drugs from a vehicle in Assam’s Nagaon district on Thursday evening.

The apprehended persons have been identified as Moon Moon Hoque, a lawyer, and Iftikhar Hussain. According to police, based on secret information, a search operation was conducted in the Morikolong area in the district and 5,871 prohibited tablets and 190 cough syrup bottles were recovered from a vehicle.

Rupjyoti Kalita, Additional Superintendent of Police of Nagaon district said, “The operation was launched on Thursday evening and we recovered 5,871 prohibited tablets and 190 cough syrup bottles from a vehicle in the Morikolong area.”

“We have also apprehended two persons while they were trying to transport the contraband drugs. Our investigation is on,” Kalita added.

A few days ago, the Assam police seized a huge quantity of contraband drugs from a Tripura-bound truck and apprehended the driver in the Karimganj district.

The police said that the driver identified as Mukesh Yadav was apprehended along the Assam-Tripura border on Monday.

They recovered eight cartoons containing 1280 bottles of cough syrup bottles whose market value is estimated at around Rs 6.50 lakh.

“Acting on a tip-off, the police of the Churaibari watch post along the Assam-Tripura border on Sunday intercepted a truck during checking, the police team recovered 1280 bottles of cough syrup from the truck,” In-Charge of the Churaibari police watch post-Niranjan Das told ANI.

According to the police, the truck (container) was coming from Guwahati and was going towards Agartala.

  • Related Posts

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Boehringer Ingelheim launches AI centre for pharma research in London

    Boehringer Ingelheim launches AI centre for pharma research in London

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March